Objectives

1. Improve quality of life in ESRD patients with moderate to severe pruritis
2. Determine whether difelikefalin is beneficial compared to standard treatment in this patient
population

Session date: 
Thursday, February 20, 2020 - 1:00pm to 2:00pm
Speaker Name: 
Abhishek Pulla, MD
Location: 
UCMC AMB S-534
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.